Date de publication : 6 mars 2025

Séminaire

Orateur : Gilles MARODON (Inserm U1135 | CIMI-PARIS | SiRiC Curamus)

Lieu : 14 MARS, 11.00 – Salles 1, 2, 3 – IRS 2

Le Dr Gilles Marodon (Inserm U1135 | CIMI-PARIS | SiRiC Curamus), invité de l’équipe 3, donnera un séminaire intitulé : Regulatory T cells control inflammatory and non-inflammatory pain through endogenous opioids , le 14 mars à 11.00 – Salles 1, 2, 3 – IRS2, Nantes

DARVAC: Inserm impact Santé

DARVAC: Inserm impact Santé

Team 3 from INCIT Lab Inserm U1302 (Nantes) is part of the Inserm Impact Santé project DARVAC "Development of vaccines offering innovative early protection against non-viral cancers" based on ghost (Dark) proteins. The project is led by Jerome Galon, with Michel...

lire plus